Next, to assess whether SYK inhibition impairs mitochondria biogenesis, we incubated primary AML blasts and TEX, KG1 and MOLM14 with R406, and assessed NRF1, TFAM, EF-Tu, and MYC mRNA levels. This evidence concerns the gene NRF1 and acute myeloid leukemia.